calico
Abbvie and Google’s Calico extend age-related disease partnership to $2.5bn
June 27, 2018Research and Development, Sales and Marketing AbbVie, Cancer, Goggle, calico, pharma
The partnership of Abbvie and Google’s Calico has announced they are to extend their existing 10-year drug discovery and development …
Google partners with Biogen on multiple sclerosis
January 30, 2015Medical Communications, Sales and Marketing Biogen, MS, calico, conrad, google, google x, scangos
Google is making further headway into healthcare by teaming up with Biogen Idec in order to study what leads to …
Google X developing diagnosis pill
October 29, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, Pfizer, calico, diagnosis pill, google, google x, vida, wearables
Google is developing a new pill designed to send microscopic particles into the bloodstream in an effort to identify cancers, …
Google’s Calico takes first steps into research
September 12, 2014Medical Communications, Sales and Marketing AbbVie, P7C3, Parkinson's, Parkinson’s, calico, depression, google, motor neurone disease
Google is finally shifting into gear within the health arena as it signs its first research deal to develop a …
Google partners with AbbVie on ageing
September 4, 2014Medical Communications, Research and Development, Sales and Marketing 23andME, AbbVie, Abbott, Roche, calico, google
Google’s healthcare company Calico has signed its first pharma pact with US firm AbbVie in a deal that could be …
Google hopes DNA search will yield health results
July 27, 2014Medical Communications, Research and Development, Sales and Marketing DNA, calico, google, smart lens
Google is to collect samples of human tissue from thousands of people as part of an experiment that could help …
Google to use contact lens as diabetes monitor
January 17, 2014Medical Communications, Sales and Marketing calico, contact, diabetes, google, lens
Google is developing a new type of contact lens designed to help patients with diabetes measure their blood sugar levels. …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
